Aging renders the brain vulnerable to 26 β-protein neurotoxicity

Nature Medicine

Volumn 4, Issue 7, 1998, Pages 827-831

  Geula, Changiz ^a,b   Wu, Chuang Kuo ^a,b   Saroff, Daniel ^a,b   Lorenzo, Alfredo ^b,c   Yuan, Menglan ^b,c   Yankner, Bruce A ^b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; MARMOSET; MICROGLIA; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; RAT;

AGING; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CALLITHRIX; MACACA MULATTA; MICE; NEURONS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RATS; SPECIES SPECIFICITY; TAU PROTEINS;

ANIMALIA; MACACA MULATTA; MARMOSETS; PRIMATES;

EID: 0031824782     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0798-827     Document Type: Article

References (36)

1. Glenner, G.G. & Wong, C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890 (1984).
2. Masters, C.L. et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249 (1985).
3. Yankner, B.A. Mechanisms of Neuronal Degeneration in Alzheimer's Disease. Neuron 16, 921-932 (1996).
4. Selkoe, D.J. Alzheimer's disease: Gentoypes, phenotypes and treatments. Science 275, 630-631 (1997).
5. Yankner, B.A., Duffy, L.K. & Kirschner, D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250, 279-282 (1990).
6. Pike, C.J., Walencewicz, A.J., Glabe, C.G. & Cotman, C.W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311-314 (1991).
7. Busciglio, J., Lorenzo, A. & Yankner, B.A. Methodological variables in the assessment of β amyloid neurotoxicity. Neurobiol. Aging 13, 609-612 (1992).
8. Mattson, M.P., Tomaselli, K.J. & Rydel, R.E. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res. 621, 35-49 (1993).
9. Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G. & Cotman, C.W. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13, 1676-1687 (1993).
10. Lorenzo, A. & Yankner, B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91, 12243-12247 (1994).
11. Howlett, D.R. et al. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegen. 4,-23-32 (1995).
12. Quon, D. et al. Formation of β-amyloid protein deposits in brains of transgenic mice. Nature 352, 239-241 (1991).
13. Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527 (1995).
14. Hsiao, K. et al. Correlative memory deficits, Abeta elevation and amyloid plaques in transgenic mice. Science 274, 99-102 (1996).
15. Sturchler-Pierrat, C. et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U.S.A. 94, 13287-13292 (1997).
16. Irizarry, M.C. et al. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17, 7053-7059 (1997).
17. Selkoe, D.J., Abraham, C.R., Podlisny, M.B. & Duffy, L.B. Isolation of low molecular wieght proteins from amyloid plaque fibers in Alzheimer's disease. J. Neurochem. 46, 1820-1834 (1986).
18. Struble, R.G., Price, D.L., Jr., Cork, L.C. & Price, D.L. Senile plaques in cortex of aged normal monkey. Brain Res. 361, 267-275 (1985).
19. Selkoe, D.J., Bell, D.S., Podlisny, M.B., Price D.L. & Cork, L.C. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 235, 873-877 (1987).
20. Mandelkov, E.M. et al. Microtubule-associated protein tau, paired helical filaments, and phosphorylation. Ann. NY Acad. Sci. 695, 209-216 (1993).
21. Kowall, N.W., Beal, M.F., Busciglio, J., Duffy, L.K. & Yankner, B.A. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA 88, 7247-7251 (1991).
22. Frautschy, S.A., Baird, A. & Cole, G.M. Effects of injected Alzheimer β-amyloid cores in rat brain. Proc. Natl. Acad. Sci. USA 88, 8362-8366 (1991).
23. Busciglio, J., Lorenzo, A., Yeh, J. & Yankner, B.A. Beta-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888 (1995).
24. Kowall, N.W., McKee, A.C., Yankner, B.A. & Beal, M.F. In vivo neurotoxicity of beta-amyloid [β(1-40)] and the β(25-35) fragment. Neurobiol. Aging 13, 537-542 (1992).
25. Podlisny, M.B. et al. Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity. Am. J. Path. 142, 17-24 (1993).
26. May, P.C. et al. Beta-Amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiol. Aging 13, 605-607 (1992).
27. Walker, L.C., Masters, C., Beyreuther, K. & Price, D.L. Amyloid in the brains of aged normal monkey. Acta Neuropathol. 80, 381-387 (1990).
28. Bons, N., Mestre, N. & Petter, A. Senile plaques and neurofibrillary changes in the brain of an aged lemurain primate, microcebus murinus. Neurobiol. Aging 13, 99-105 (1991).
29. Martin, L.J., Pardo, C.A., Cork, L.C. & Price, D.L. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145, 1358-1381 (1994).
30. Crook, R. et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nature Med. 4, 452-455 (1998).
31. Wisniewski, K.E., Wisniewski, H.M. & Wen, G.Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17, 278-282 (1985).
32. Meda, L. et al. Activation of microglial cells by β-amyloid protein and interferon-β. Nature 374, 647-650 (1995).
33. Giulian, D. et al. Specific domains of β-amyloid from Alzheimer plague elicit neuron killing in human microglia. J. Neurosci. 16, 6021-6037 (1996).
34. Weldon, D.T. et al. Fibrillar β-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J. Neurosci. 18, 2161-2173 (1998).
35. Frey, P., Sunderji, S. & Waridel, C. in Alzheimer's Disease: Biology, Diagnosis and Therapeutics (eds. Iqbal, K., Winblad, B., Nishimura, T., Takeda, M. & Wisniewski, H.M.) 447-453 (Wiley and Sons, Chichester, 1997).
36. Greenberg, S.C. & Davies, P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl. Acad. Sci. U.S.A. 87, 5827-5831 (1990).